This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Vermillion Corporation. Active years: 2014-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Winchester, MA (US) (2014 - 2016)
- Austin, TX (US) (2017 - 2020)
Company Filing History:
Years Active: 2014-2020
Title: **Innovations of Ping F Yip: Pioneering Predictive Biomarkers for Ovarian Cancer**
Introduction
Ping F Yip, an accomplished inventor based in Austin, TX, has made significant contributions to the field of cancer diagnostics. With a total of four patents under his name, his work focuses primarily on predicting and assessing ovarian cancer, a crucial area in enhancing treatment outcomes.
Latest Patents
Among his latest innovations are methods for predicting the presence, subtype, and stage of ovarian cancer. These methodologies also assess the therapeutic efficacy of cancer treatments and determine potential cancer development in patients. His inventions include associated test kits, computer and analytical systems, as well as software and diagnostic models that support these predictive techniques.
Career Highlights
Ping F Yip is currently affiliated with Vermillion Corporation, where he continues to advance the development of cancer diagnostic technologies. His expertise and innovations play a pivotal role in the company's efforts to enhance patient outcomes through advanced biomarker discovery.
Collaborations
Throughout his career, he has collaborated with esteemed colleagues such as Brian C Mansfield and Suraj Amonkar. These partnerships foster an environment of innovation and drive the collective pursuit of breakthroughs in the medical field.
Conclusion
Ping F Yip's work exemplifies the spirit of innovation within the healthcare industry. His patents and contributions to ovarian cancer diagnostics not only reflect his ingenuity but also offer hope for improved patient care and treatment efficacy. As he continues to push the boundaries of science, his impact on cancer research remains significant and inspiring.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
